Ilex Medical (XTAE:ILX) Piotroski F-Score: 5 (As of Sep. 04, 2026) — 17% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ILX Ilex Medical Ltd XTAE:ILX
67 GF Score
Price ₪51.13
GF Value ₪61.30
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ilex Medical Piotroski F-Score?

Ilex Medical XTAE:ILX -0.08% 67 Piotroski F-Score is 5 as of Sep. 04, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates XTAE:ILX with a GF Score™ of 67/100 and a GF Value™ of ₪61.30 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Ilex Medical ranks better than 63.11% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ilex Medical has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Ilex Medical's Piotroski F-Score or its related term are showing as below:

XTAE:ILX' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Ilex Medical was 8. The lowest was 3. And the median was 6.

Ilex Medical  (XTAE:ILX) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Ilex Medical Piotroski F-Score Related Terms


Ilex Medical Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Ilex Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ilex Medical Piotroski F-Score Chart

Ilex Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 4.00 6.00 5.00 7.00

Ilex Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 7.00 6.00 5.00

XTAE:ILX vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Ilex Medical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ilex Medical Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ilex Medical's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Ilex Medical's Piotroski F-Score falls into.


XTAE:ILX
67GF Score
Ilex Medical Ltd XTAE:ILX
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 10.988 + 18.533 + 4.918 + 4.465 = ₪38.9 Mil.
Cash Flow from Operations was 14.439 + -1.406 + 25.757 + 47.068 = ₪85.9 Mil.
Revenue was 227.57 + 245.689 + 213.574 + 198.515 = ₪885.3 Mil.
Gross Profit was 51.996 + 55.35 + 48.626 + 41.602 = ₪197.6 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(947.256 + 969.922 + 992.738 + 971.243 + 955.925) / 5 = ₪967.4168 Mil.
Total Assets at the begining of this year (Jun25) was ₪947.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₪36.4 Mil.
Total Current Assets was ₪631.1 Mil.
Total Current Liabilities was ₪205.8 Mil.
Net Income was 12.958 + 6.614 + 9.111 + 16.923 = ₪45.6 Mil.

Revenue was 238.041 + 231.959 + 238.26 + 219.314 = ₪927.6 Mil.
Gross Profit was 58.959 + 52.517 + 54.896 + 49.641 = ₪216.0 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(997.717 + 1007.769 + 994.067 + 987.086 + 947.256) / 5 = ₪986.779 Mil.
Total Assets at the begining of last year (Jun24) was ₪997.7 Mil.
Long-Term Debt & Capital Lease Obligation was ₪33.7 Mil.
Total Current Assets was ₪675.4 Mil.
Total Current Liabilities was ₪218.5 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ilex Medical's current Net Income (TTM) was 38.9. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ilex Medical's current Cash Flow from Operations (TTM) was 85.9. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=38.904/947.256
=0.04107021

ROA (Last Year)=Net Income/Total Assets (Jun24)
=45.606/997.717
=0.04571036

Ilex Medical's return on assets of this year was 0.04107021. Ilex Medical's return on assets of last year was 0.04571036. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Ilex Medical's current Net Income (TTM) was 38.9. Ilex Medical's current Cash Flow from Operations (TTM) was 85.9. ==> 85.9 > 38.9 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=36.39/967.4168
=0.03761564

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=33.73/986.779
=0.03418192

Ilex Medical's gearing of this year was 0.03761564. Ilex Medical's gearing of last year was 0.03418192. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=631.146/205.801
=3.0667781

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=675.37/218.532
=3.0904856

Ilex Medical's current ratio of this year was 3.0667781. Ilex Medical's current ratio of last year was 3.0904856. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Ilex Medical's number of shares in issue this year was 11.163. Ilex Medical's number of shares in issue last year was 11.207. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=197.574/885.348
=0.22315971

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=216.013/927.574
=0.23287953

Ilex Medical's gross margin of this year was 0.22315971. Ilex Medical's gross margin of last year was 0.23287953. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=885.348/947.256
=0.93464491

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=927.574/997.717
=0.9296965

Ilex Medical's asset turnover of this year was 0.93464491. Ilex Medical's asset turnover of last year was 0.9296965. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+1+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ilex Medical has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Ilex Medical (XTAE:ILX) has a Piotroski F-Score of 5 as of Sep. 04, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ilex Medical and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Ilex Medical's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Ilex Medical ranks #301 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 36.9%.
Is Ilex Medical's Piotroski F-Score too high?
Ilex Medical's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Ilex Medical's value of 5 is 0% at this industry median. Based on the distribution chart, Ilex Medical ranks #301 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ilex Medical has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ilex Medical's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ilex Medical ranks #301 out of 816 companies for Piotroski F-Score. This puts Ilex Medical in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Ilex Medical's value of 5 is 0% at this benchmark. Historically, Ilex Medical's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Ilex Medical has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ilex Medical's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ilex Medical and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ilex Medical's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ilex Medical stock overvalued right now?
Based on GuruFocus' analysis, Ilex Medical (XTAE:ILX) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪61.30, compared to a current price of ₪51.13 — trading 16.6% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Medical Devices & Instruments industry median of 5.00. Ilex Medical's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Ilex Medical (XTAE:ILX), the current Piotroski F-Score is 5 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ilex Medical (XTAE:ILX) Overvalued in 2026?

Based on GuruFocus' analysis, Ilex Medical stock appears to be undervalued. The current stock price of ₪51.13 is trading 16.6% below its estimated GF Value™ of ₪61.30. GuruFocus considers Ilex Medical to be Modestly Undervalued.

Key valuation signals for XTAE:ILX:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: ₪61.30 vs. price of ₪51.13 (16.6% below fair value)
  • GF Score™: 67/100 with 5 warning signs
  • Industry Position: 0% at the Medical Devices & Instruments median (#301 of 816)

No single metric tells the full story. See the XTAE:ILX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ilex Medical Business Description

Address Kodak Building, 7 Hatnufa Street, PO Box 3156, Kiriat Arie Industrial Park, Petah Tikva, ISR, 4951025
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
67GF Score

Get the complete analysis for XTAE:ILX

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪51.13
Price
₪61.30
GF Value